Recall of all batches of Hyalgan 20mg-2ml pre-filled syringe manufactured by Fidia Farmaceutical S.P
2026-04-20
الاسم التجاري الاسم العلمي رقم التسجيل رقم التشغيلة المتأثرة الشركة الصانعة Trade Name Scientific Name Register Number Affected batch number Manufacturer Hyalgan 20mg-2ml pre-filled syringe Sodium Hyaluronate 1-427-05 All batches Fidia Farmaceutical S.P.A
التصنيف
ملف
التاريخ
2026-03-11
اسم المستحضر
Hyalgan 20mg-2ml pre-filled syringe
اجراء الاستدعاء
مستوى الاستدعاء
نوع المستحضر
سبب السحب
SFDA has issued a recall of all batches of Hyalgan 20mg-2ml pre-filled syringe due to Non-compliance with Good Manufacturing Practice (GMP) requirements, which may impact the safety and quality of the product.
التوصيات
For healthcare professionals: Stop dispensing the all batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.
For patients,
Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.